EMEA-000347-PIP02-16-M02

Table of contents

Key facts

Invented name
Bilaxten and associated names
Active substance
Bilastine
Therapeutic area
Ophthalmology
Decision number
P/0466/2020
PIP number
EMEA-000347-PIP02-16-M02
Pharmaceutical form(s)
Eye drops, solution
Condition(s) / indication(s)
Treatment of allergic conjunctivitis
Route(s) of administration
Ocular use
Contact for public enquiries
Faes Farma S.A.

Tel.  + 34 94818300

E-mail: mjarenal@faes.esieguidazu@faes.es

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating